1. Home
  2. FOLD vs AGM Comparison

FOLD vs AGM Comparison

Compare FOLD & AGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • AGM
  • Stock Information
  • Founded
  • FOLD 2002
  • AGM 1987
  • Country
  • FOLD United States
  • AGM United States
  • Employees
  • FOLD N/A
  • AGM N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • AGM Finance Companies
  • Sector
  • FOLD Health Care
  • AGM Finance
  • Exchange
  • FOLD Nasdaq
  • AGM Nasdaq
  • Market Cap
  • FOLD 2.5B
  • AGM 2.3B
  • IPO Year
  • FOLD 2007
  • AGM N/A
  • Fundamental
  • Price
  • FOLD $8.15
  • AGM $157.63
  • Analyst Decision
  • FOLD Strong Buy
  • AGM Hold
  • Analyst Count
  • FOLD 9
  • AGM 1
  • Target Price
  • FOLD $26.44
  • AGM $217.00
  • AVG Volume (30 Days)
  • FOLD 5.8M
  • AGM 85.9K
  • Earning Date
  • FOLD 11-05-2025
  • AGM 11-03-2025
  • Dividend Yield
  • FOLD N/A
  • AGM 3.82%
  • EPS Growth
  • FOLD N/A
  • AGM 3.61
  • EPS
  • FOLD N/A
  • AGM 16.97
  • Revenue
  • FOLD $571,160,000.00
  • AGM $368,431,000.00
  • Revenue This Year
  • FOLD $20.98
  • AGM $12.46
  • Revenue Next Year
  • FOLD $20.74
  • AGM $8.69
  • P/E Ratio
  • FOLD N/A
  • AGM $9.26
  • Revenue Growth
  • FOLD 25.35
  • AGM 2.95
  • 52 Week Low
  • FOLD $5.51
  • AGM $156.96
  • 52 Week High
  • FOLD $12.65
  • AGM $217.14
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 56.40
  • AGM 15.82
  • Support Level
  • FOLD $7.69
  • AGM $195.00
  • Resistance Level
  • FOLD $8.59
  • AGM $167.35
  • Average True Range (ATR)
  • FOLD 0.37
  • AGM 4.85
  • MACD
  • FOLD -0.05
  • AGM -2.38
  • Stochastic Oscillator
  • FOLD 54.44
  • AGM 0.61

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.

Share on Social Networks: